dehaze is a company headquartered in Germany. Brouky records 1 investor associated with the company.
Dehaze uses AI to analyze diverse patient health data and identify overlooked diagnoses, inappropriate treatments, and future health risks to enable proactive management of chronic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.